BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9040028)

  • 1. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.
    Diaz RJ; Wilson GJ
    J Mol Cell Cardiol; 1997 Jan; 29(1):129-39. PubMed ID: 9040028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
    Bugge E; Ytrehus K
    J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
    Wang P; Gallagher KP; Downey JM; Cohen MV
    J Mol Cell Cardiol; 1996 Mar; 28(3):579-88. PubMed ID: 9011641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
    Weinbrenner C; Schulze F; Sárváry L; Strasser RH
    Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation].
    Miki T; Miura T; Tsuchida A; Nakano A; Hasegawa T; Fukuma T; Shimamoto K
    J Cardiol; 2001 Feb; 37(2):112-3. PubMed ID: 11255694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium.
    Baines CP; Goto M; Downey JM
    J Mol Cell Cardiol; 1997 Jan; 29(1):207-16. PubMed ID: 9040035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
    Parlakpinar H; Ozer MK; Acet A
    Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
    Xu Y; Menon V; Jugdutt BI
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs.
    Vahlhaus C; Schulz R; Post H; Rose J; Heusch G
    J Mol Cell Cardiol; 1998 Feb; 30(2):197-209. PubMed ID: 9514996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart.
    Hill RJ; Oleynek JJ; Magee W; Knight DR; Tracey WR
    J Mol Cell Cardiol; 1998 Mar; 30(3):579-85. PubMed ID: 9515033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II fails to induce preconditioning in vivo--the protective role of myocardial stretch due to pressure overload.
    Iliodromitis EK; Vlahakos DV; Bofilis E; Karavolias GK; Tasouli A; Kremastinos DT
    Can J Cardiol; 2002 Jan; 18(1):34-42. PubMed ID: 11826327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
    Jalowy A; Schulz R; Heusch G
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats.
    Sladek T; Sladkova J; Kolar F; Papousek F; Cicutti N; Korecky B; Rakusan K
    Cardiovasc Res; 1996 Apr; 31(4):568-76. PubMed ID: 8689648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart.
    Kositprapa C; Ockaili RA; Kukreja RC
    J Mol Cell Cardiol; 2001 Jul; 33(7):1355-62. PubMed ID: 11437541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple cycles of preconditioning cause loss of protection in open-chest rabbits.
    Iliodromitis EK; Kremastinos DT; Katritsis DG; Papadopoulos CC; Hearse DJ
    J Mol Cell Cardiol; 1997 Mar; 29(3):915-20. PubMed ID: 9152852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
    Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
    J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs.
    Sebbag L; Katsuragawa M; Verbinski S; Jennings RB; Reimer KA
    Cardiovasc Res; 1996 Nov; 32(5):830-8. PubMed ID: 8944813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.